PD-L1 expression in non-small cell lung cancer: heterogeneity by pathologic types, tissue sampling and metastasis

BACKGROUND: Programmed cell death ligand-1 (PD-L1) is a predictive marker of anti-PD-1/PD-L1 therapy response. Intra-tumour heterogeneity of PD-L1 expression has been reported in non-small cell lung cancer (NSCLC), but comprehensive studies regarding the determination of PD-L1 expression in differen...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Xuxia, Wang, Yue, Jin, Yan, Zheng, Qiang, Shen, Lei, Chen, Ying, Li, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339751/
https://www.ncbi.nlm.nih.gov/pubmed/34422362
http://dx.doi.org/10.21037/jtd-21-388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339751/
https://www.ncbi.nlm.nih.gov/pubmed/34422362
http://dx.doi.org/10.21037/jtd-21-388

Ejemplares similares